Proteomic patterns for cancer diagnosis - Promise and challenges

Molecular BioSystems

Volumn 2, Issue 8, 2006, Pages 358-363

  Whiteley, Gordon R ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; TUMOR PROTEIN;

BIOLOGICAL MODEL; BIOLOGY; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MICRODISSECTION; NEOPLASM; PROTEIN MICROARRAY; PROTEOMICS; REVIEW;

COMPUTATIONAL BIOLOGY; HUMANS; MICRODISSECTION; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 33745955373     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/b607260g     Document Type: Review

References (41)

1. G. Mor I. Visintin Y. Lai H. Ahao P. Schwartz T. Rutherford L. Yue P. Bray-Ward D. C. Ward Serum protein markers for early detection of ovarian cancer Proc. Natl. Acad. Sci. U. S. A. 2005 102 7677 7682
2. H. M. Meyer Status of the CEA test Hum. Pathol. 1973 4 298
3. D. P. Stevens I. R. Mackay K. J. Cullen Carcinoembryonic antigen in an unselected elderly population: a four year follow up Br. J. Cancer 1975 32 1477 151
4. R. Lee A. R. Localio K. Armstrong S. B. Malkowicz J. S. Schwartz A meta-analysis of the performance characteristics of the free prostate-specific antigen test Adult Urol. 2006 67 762 768
5. R. J. Babaian Y. Naya C. Cheli H. A. Fritsche The detection and potential economic value of complexed prostate specific antigen as a first line test J. Urol. 2006 175 897 901
6. G. Abbott Proteomics, transcriptomics; what's in a name? Nature 1999 202 715 716
7. E. F. Petricoin A. M. Ardekani B. A. Hitt Use of proteomic patterns in serum to identify ovarian cancer Lancet 2002 359 572 7
8. K. R. Kozak M. W. Amneus S. M. Pusey F. Su M. N. Loung S. A. Loung S. T. Reddy R. Farias-Eisner Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis Proc. Natl. Acad. Sci. U. S. A. 2003 100 12343 12348
9. -1 J. Urol. 2004 172 1302 5
10. J. Koopmann Z. Zhang N. White Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization MS Clin. Cancer Res. 2004 10 860 8
11. L. L. Liotta V. Espina A. I. Mehta V. Calvert K. Rosenblatt D. Geho P. J. Munson L. Young J. Wulfkuhle E. F. Petricoin Protein microarrays: Meeting analytical challenges for clinical applications Cancer Cell 2003 3 317 325
12. M. Cretich F. Damin G. Pirri M. Chiari Protein and peptide arrays: Recent trends and new directions Biomol. Eng. 2006 23 77 88
13. Y. Hu M. Uttamchandani S. Q. Yao Microarray: A versatile platform for high-throughput functional proteomics Comb. Chem. High Throughput Screening 2006 9 203 212
14. S. F. Kingsmore Multiplexed protein measurement: technologies and applications of protein and antibody arrays Nat. Rev. Drug Discovery 2005 5 310 321
15. J. E. Nowak M. Chatterjee S. Mohapatra S. C. Dryden M. A. Tainsky Direct production and purification of T7 phage display cloned proteins selected and analyzed on microarrays BioTechniques 2006 40 220 227
16. M. Chatterjee S. Mohapatra A. Ionan G. Bawa R. Ali-Fehmi X. Wang J. Nowak B. Ye F. A. Nahhas K. Lu S. S. Witkin D. Fishman A. Mankarah R. Morris N. K. Levin N. N. Shirley G. Tromp J. Abrams S. Braghici M. A. Tainsky Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays Cancer Res. 2006 66 1181 1190
17. V. Espina E. C. Woodhouse J. Wulfkuhle H. D. Asmussen E. F. Petricoin L. A. Liotta Protein microarray detection strategies: focus on direct detection technologies J. Immunol. Methods 2004 290 121 133
18. D. Geho N. Lahar P. Gurnani M. Huebschman P. Herrmann V. Espina A. Shi J. Wulfkuhle H. Garner E. Petricoin L. A. Liotta K. P. Rosenblatt Pegylated, streptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays Bioconjugate Chem. 2005 16 559 566
19. M. R. Emmert-Buck R. F. Bonner P. D. Smith R. F. Chauqui Z. Zhuang S. R. Goldstein R. A. Weiss L. A. Liotta Laser capture microdissection Science 1996 274 998 1001
20. D. K. Ornstein J. W. Gillespie C. P. Paweletz P. H. Buray J. Herring C. D. Vocke S. L. Topalian D. G. Bostwick W. M. Linehan E. F. Petricoin M. R. Emmert-Buck Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines Electrophoresis 2000 21 2235 2242
21. C. P. Paweletz J. W. Gillespie D. K. Ornstein N. L. Simmone M. R. Brown K. A. Cole Q-H. Wang J. Huang N. Hu T. T. Yipe W. E. Rich E. C. Kohn W. M. Linehan T. Weber P. Taylor M. R. Emmert-Buck L. A. Liotta E. F. Petricoin Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip Drug Dev. Res. 2000 49 34 42
22. Z. Zhang R. C. Bast Y. Yu Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res. 2004 4 5882 90
23. -1 J. Urol. 2004 172 1302 5
24. J. Koopmann Z. Zhang N. White Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization MS Clin. Cancer Res. 2004 10 860 8
25. E. F. Diamandis Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems J. Nat. Cancer Inst. 2004 96 353 356
26. K. A. Baggerly J. S. Morris K. R. Coombes Reproducibility of SELDI-TOF protein patterns in serum: Comparing datasets from different experiments Bioinformatics 2004 20 777 785
27. L. A. Liotta M. Lowenthal A. Mehta T. P. Conrads T. D. Veenstra D. A. Fishman E. F. Petricoin Importance of communication between producers and consumers of publicly available experimental data J. Nat. Cancer Inst. 2005 97 310 314
28. G. L. Horton Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin. Chem. 2005 51 3 5
29. T. P. Conrads V. A. Fusaro S. Ross D. Johann V. Rajapakse B. A. Hitt S. M. Steinberg E. C. Kohn D. A. Fishman G. Whiteley J. C. Barrett L. A. Liotta E. F. Petricoin T. D. Veenstra High-resolution serum proteomic features for ovarian cancer detection Endocr. Relat. Cancer 2004 2 163 178
30. A. Mehta S. Ross M. S. Lowenthal Biomarker Amplification by Serum Carrier Protein Binding Dis. Markers 2004 19 1 10
31. L. A. Liotta M. Ferrari E. Petricoin Clinical proteomics: written in blood Nature 2003 425 6961 905
32. M. F. Lopez A. Mikulskis S. Kuzdzal D. A. Bennett J. Kelly High-Resolution Serum proteomic Profilino of Alzheimer Disease Samples Reveals Disease-Specific, Carrier-Protein-Bound Mass Signatures Clin. Chem. 51 1946 1954
33. A. J. Rai Z. Zhang J. Rosenzweig L-M. Shih T. Pham E. T. Fung L. J. Sokoll D. W. Chan Proteomic approaches to tumor marker discovery: Identification of Biomarkers for Ovarian Cancer Arch. Pathol. Lab. Med. 2002 126 1518 1526
34. R. L. Moritz R. J. Simpson Liquid-based free-flow electrophoresis reversed-phase HPLC: a proteomic tool Nat. Methods 2005 2 863 873
35. Y. Wang W. S. Hancock G. Weber C. Eckerskorn D. Palmer-Toy Free flow electrophoresis coupled with liquid chromatography-mass spectrometry for a proteomic study of the human cell line (K562/CR3) J. Chromatogr., A. 2004 1053 269 278
36. L. J. Zimmerman G. R. Wernke R. M. Caprioli D. C. Liebler Identification of protein fragments as pattern features in MALDI-MS analyses of serum J. Proteome Res. 2005 4 1672 1680
37. G. Siuzdak, The Expanding Role of Mass Spectrometry in Biotechnology, MCC Press, San Diego 2003; ISBN 0-9742451-0-0
38. C. Belluco E. Petricoin C. Peschle C. Liu M. Lowenthal D. Johann L. Lasebikan S. Ross-Rucker M. Lise C. DiMaggio E. Mammano F. Facchiano D. Nitti E. Garaci G. B. Mills G. Whiteley LMW protein fragments may detect early stage breast cancer Cancer Res.
39. D. J. Johann M. D. McGuigan S. Tomov V. A. Fusaro S. Ross T. P. Conrads T. D. Veenstra D. A. Fishman G. R. Whiteley E. F. Petricoin L. A. Liotta Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients Dis. Markers 2003-2004 19 197 207
40. C. Menard D. Johann M. Lowenthal T. Muanza M. Sproull S. Ross J. Gulley E. Petricoin C. N. Coleman G. Whiteley L. Liotta K. Camphausen Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis Cancer Res. 2006 66 1844 1850
41. D. Nedelkov R. W. Nelson Surface plasmon resonance mass spectrometry: recent progress and outlooks Trends Biotechnol. 2003 21 301 305